Structural Basis for Interaction of Inhibitors with Cyclin-Dependent Kinase 2

Publisher： Bentham Science Publishers

E-ISSN： 1875-6697|1|1|53-64

ISSN： 1573-4099

Source： Current Computer - Aided Drug Design, Vol.1, Iss.1, 2005-01, pp. : 53-64

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Cyclin-dependent kinase inhibitors closer to market launch?

By Galons Hervé  

Expert Opinion on Therapeutic Patents, Vol. 23, Iss. 8, 2013-08 ,pp. : 945-963

Informa Healthcare

Access to resources Recommend Favorite

Cyclin-dependent kinase inhibitors: novel anticancer agents

By Mani S.   Wang C.   Wu K.   Francis R.   Pestell R.  

Expert Opinion on Investigational Drugs, Vol. 9, Iss. 8, 2000-08 ,pp. : 1849-1870

Informa Healthcare

Access to resources Recommend Favorite

Cyclin-Dependent Kinase Inhibitors as Anticancer Drugs

By  

Current Drug Targets, Vol. 11, Iss. 3, 2010-03 ,pp. : 291-302

Bentham Science Publishers

Access to resources Recommend Favorite

Cyclin-Dependent Kinase-2 as a Target for Cancer Therapy: Progress in the Development of CDK2 Inhibitors as Anti-Cancer Agents

By  

Current Medicinal Chemistry, Vol. 22, Iss. 2, 2014-12 ,pp. : 237-263

Bentham Science Publishers

Access to resources Recommend Favorite

Synthesis and biological evaluations of pyrazolo[3,4-d]pyrimidines as cyclin-dependent kinase 2 inhibitors

By Kim D.C.   Lee Y.R.   Yang B.-S.   Shin K.J.   Kim D.J.   Chung B.Y.   Yoo K.H.  

European Journal of Medicinal Chemistry, Vol. 38, Iss. 5, 2003-05 ,pp. : 525-532

Elsevier

Access to resources Recommend Favorite